Spero-Smith Investment Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$257K Sell
2,179
-263
-11% -$31.9K 0.34% 45
2016
Q2
$296K Hold
2,442
0.37% 44
2016
Q1
$264K Buy
2,442
+400
+20% +$41.4K 0.33% 44
2015
Q4
$210K Sell
2,042
-2,000
-49% -$201K 0.27% 46
2015
Q3
$377K Hold
4,042
0.51% 38
2015
Q2
$394K Sell
4,042
-67
-2% -$6.71K 0.45% 40
2015
Q1
$413K Hold
4,109
0.46% 40
2014
Q4
$429K Buy
4,109
+2,000
+95% +$211K 0.49% 38
2014
Q3
$224K Buy
+2,109
New +$219K 0.26% 42

Other funds holding JNJ

Spero-Smith Investment Advisers's JNJ Position: Q3 2016 in Review

Spero-Smith Investment Advisers reduced its Johnson & Johnson (JNJ) stake by 11% in Q3 2016, selling an estimated $31.9K and leaving 2,179 shares worth $257K. The position accounts for 0.34% of the portfolio, ranked #45.

Spero-Smith Investment Advisers first reported a position in JNJ in Q3 2014 and has held it in 9 quarters since. The position peaked at $429K in Q4 2014. 2,228 funds tracked by Wall St. Rank hold JNJ as of Q3 2016.

  • Spero-Smith Investment Advisers held 2,179 shares of Johnson & Johnson worth $257K as of Q3 2016.
  • Spero-Smith Investment Advisers sold 263 Johnson & Johnson shares in Q3 2016, an estimated $31.9K.
  • Johnson & Johnson made up 0.34% of Spero-Smith Investment Advisers's portfolio in Q3 2016, its #45 holding.
  • Spero-Smith Investment Advisers first reported a position in Johnson & Johnson in Q3 2014 and has held it in 9 quarters since.
  • Spero-Smith Investment Advisers's Johnson & Johnson position peaked at $429K in Q4 2014.
  • 2,228 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2016.

Based on Spero-Smith Investment Advisers's 13F filing for Q3 2016, filed 31 Oct 2016.